ChemicalBook > Product Catalog >Biochemical Engineering >Inhibitors >Mitogen-activated protein kinase (MAPK) >MEK inhibitor >PD 0325901

PD 0325901

PD 0325901 Suppliers list
Company Name: Capot Chemical Co.,Ltd.
Tel: 571-85586718 +8613336195806
Email: sales@capotchem.com
Products Intro: Product Name:PD 0325901
CAS:391210-10-9
Purity:98%(Min,HPLC) Package:100g;1kg;5kg,10kg,25kg,50kg
Company Name: ATK CHEMICAL COMPANY LIMITED
Tel: +undefined-21-51877795
Email: ivan@atkchemical.com
Products Intro: Product Name:Mirdametinib
CAS:391210-10-9
Purity:98% Package:10MG;50MG;100MG,1G,5G,10G.100G
Company Name: career henan chemical co
Tel: +86-0371-86658258
Email: sales@coreychem.com
Products Intro: Product Name:PD 0325901
CAS:391210-10-9
Purity:98% Package:1KG;3USD
Company Name: Biochempartner
Tel: 0086-13720134139
Email: candy@biochempartner.com
Products Intro: Product Name:PD0325901
CAS:391210-10-9
Purity:98% HPLC LCMS Package:10G;20G
Company Name: BOC Sciences
Tel: +1-631-485-4226
Email: inquiry@bocsci.com
Products Intro: Product Name:PD0325901
CAS:391210-10-9
Purity:>98% Package:100mg Remarks:BOC Sciences also provides custom synthesis services for PD0325901.

PD 0325901 manufacturers

  • PD 0325901
  • PD 0325901 pictures
  • $3.00 / 1KG
  • 2019-08-27
  • CAS:391210-10-9
  • Min. Order: 3KG
  • Purity: 98%
  • Supply Ability: 1kg,5kg,100kg
PD 0325901 Basic information
Product Name:PD 0325901
Synonyms:N-[(2R)-2,3-DIHYDROXYPROPOXY]-3,4-DIFLUORO-2-[(2-FLUORO-4-IODOPHENYL)AMINO]-BENZAMIDE;PD 0325901;(R)-N-(2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodophenylamino)benzamide;PD-0235901;N-[(2R)-2,3-Dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)aMino]be;N-[(R)-2,3 -Dihydroxy-propoxy]-3,4-difluoro-2-(2-fluoro-4-iodo-phenylaMino)-benzaMide;N-[(2R)-2,3-Dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide PD0325901;PD 0325901 N-[(2R)-2,3-Dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide
CAS:391210-10-9
MF:C16H14F3IN2O4
MW:482.19
EINECS:687-152-7
Product Categories:MAPK;Inhibitor;Inhibitors;Aromatics;Chiral Reagents;Intermediates & Fine Chemicals;Pharmaceuticals;API
Mol File:391210-10-9.mol
PD 0325901 Structure
PD 0325901 Chemical Properties
Melting point 112-114°C
density 1.817±0.06 g/cm3(Predicted)
storage temp. 2-8°C
solubility DMSO: soluble20mg/mL, clear
form White to off-white solid
pka13.45±0.20(Predicted)
color white to off-white
optical activity[α]/D -1.8 to -3.5°, c = 1 mg/mL in methanol
Stability:Stable for 1 year from date of purchase as supplied. Solutions in DMSO or ethanol may be stored at -20° for up to 3 months.
InChIKeySUDAHWBOROXANE-SECBINFHSA-N
Safety Information
Hazard Codes T,N
Risk Statements 25-48-50
Safety Statements 22-36/37/39-61
RIDADR UN 2811 6.1 / PGIII
WGK Germany 3
HazardClass IRRITANT
HS Code 29242990
MSDS Information
PD 0325901 Usage And Synthesis
DescriptionPD 325901 (391210-10-9) is a selective non-ATP competitive MEK inhibitor (IC50 = 0.33 nM).1 Inhibits growth and/or proliferation of a variety of cancer cells.2 Enhances self-renewal of embryonic stem cells.3 In combination with vitamin C, synergistically induces hypomethylation of mouse embryonic stem cells.4 In combination with CHIR-99021 and A83-01 induces generation of ground state iPS cells from human and rat somatic cells.5
Chemical PropertiesWhite to Off-White Solid
UsesPD 0325901 has been used as an inhibitor in extracellular signal-regulated kinase (ERK) inhibition assay in primed induced pluripotent stem cells, RKO colorectal cancer cell line and human embryonic stem cells(hESCs).
UsesThe mitogenic extracellular kinase 1/2 (MEK1/2) inhibitor
DefinitionChEBI: A hydroxamic acid ester that is benzhydroxamic acid (N-hydroxybenzamide) in which the hydroxamic acid group has been converted to the corresponding 2,3-dihydroxypropyl ester and in which the benzene ring has been substituted at position by a (2-fluoro-4-iodophenyl)amino group and at positions 3 and 4 by fluorines (the R enantiomer).
Biochem/physiol ActionsPD 0325901 is a potent MKK1 (MEK1) and MKK2 (MEK2) inhibitor. The Ki is 1.1 and 0.79 nM for MEK1 and MEK2, respectively. PD 0325901 was inactive against a panel of 27 other kinases. PD 0325901 inhibited C26 tumor pERK by 75% when dosed at 25 mg/kg in mice.
storage-20°C
References1) Sebolt-Leopold et al. (2004), The biological profile of PD0325901: A second generation analog of CI-1040 with improved pharmaceutical potential; Proc. Amer. Assoc. Cancer Res., 45 925 2) Ciuffreda et al. (2009), Growth-inhibitor and antiangiogenic activity of the MEK inhibitor PD0325901 in malignant melanoma with or without BRAF mutations; Neoplasia, 11 720 3) Ai et al. (2016), Maintenance of Self-Renewal and Pluripotency in J1 Mouse Embryonic Stem Cells through Regulating Transcription Factor and MicroRNA Expression Induced by PD0325901; Stem Cells Int., 2016 1792573 4) Li et al. (2016), MEK inhibitor PD0325901 and vitamin C synergistically induce hypomethylation of mouse embryonic stem cells; Oncotarget, 7 39730 5) Li et al. (2009), Generation of rat and human induced pluripotent stem cells by combining genetic reprogramming and chemical inhibitors; Cell Stem Cell, 4 16
PD 0325901 Preparation Products And Raw materials
Tag:PD 0325901(391210-10-9) Related Product Information
PD 123319 ditrifluoroacetate PD 166285 PD173955 PD 166793 PD 98059 PD184352 PD318088 PRND Y27632 (hydrochloride) Selumetinib MK-2206 2HCl SB 431542 Trametinib CHIR-99021 PD 166866 PD 173074 2-Fluoro-4-iodoaniline PD 0325901